SIBN SI-BONE, Inc.Stock Price & Overview
$15.00
Charts
Quant Ranking
SIBN Analysis
SIBN News
Latest Headlines
Ratings Summary
People Also Follow
Similar to SIBN
ETFs Holding SIBN
SIBN Company Profile
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Revenue
SIBN Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
SIBN Ownership
SIBN Peers
Risk
Technicals
SIBN Transcripts
Investor Presentations
SIBN SEC Filings
Press Releases
SIBN Income Statement
SIBN Balance Sheet
SIBN Cash Flow Statement
SIBN Long Term Solvency
Discover More
You may be interested in: